Articles by tag: cellular-reprogramming

Sam Altman's $180M Investment in Anti-Aging via AI and Cells

Analysis of Sam Altman's investments in Retro Biosciences, GPT-4b micro AI model, and cellular reprogramming. Real prospects, risks, and competitors. Read details.

Mesenchymal drift: a new mechanism of aging and Alzheimer's treatment

Discovery of mesenchymal drift — key to cell rejuvenation. A clinical trial for Alzheimer's disease treatment starts with 240 patients. Learn more.

MIT synthetic circuit reverses cellular aging

MIT scientists reprogrammed cell aging without cancer risk. Learn how the genetic switch works and when to expect therapy. Read more.